Viibryd Market
1 Viibryd (Vilazodone) Market Overview
1.1 Product Overview and Scope of Viibryd (Vilazodone)
1.2 Viibryd (Vilazodone) Segment by Type
1.2.1 Global Viibryd (Vilazodone) Sales Growth Rate Comparison by Type (2023-2029)
1.2.2 10 mg
1.2.3 20 mg
1.2.4 40 mg
1.3 Viibryd (Vilazodone) Segment by Application
1.3.1 Global Viibryd (Vilazodone) Sales Comparison by Application: (2023-2029)
1.3.2 Major Depression
1.3.3 Anxiety
1.3.4 Others
1.4 Global Viibryd (Vilazodone) Market Size Estimates and Forecasts
1.4.1 Global Viibryd (Vilazodone) Revenue 2018-2029
1.4.2 Global Viibryd (Vilazodone) Sales 2018-2029
1.4.3 Viibryd (Vilazodone) Market Size by Region: 2018 Versus 2022 Versus 2029
2 Viibryd (Vilazodone) Market Competition by Manufacturers
2.1 Global Viibryd (Vilazodone) Sales Market Share by Manufacturers (2018-2023)
2.2 Global Viibryd (Vilazodone) Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Viibryd (Vilazodone) Average Price by Manufacturers (2018-2023)
2.4 Manufacturers Viibryd (Vilazodone) Manufacturing Sites, Area Served, Product Type
2.5 Viibryd (Vilazodone) Market Competitive Situation and Trends
2.5.1 Viibryd (Vilazodone) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Viibryd (Vilazodone) Players Market Share by Revenue
2.5.3 Global Viibryd (Vilazodone) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Viibryd (Vilazodone) Retrospective Market Scenario by Region
3.1 Global Viibryd (Vilazodone) Retrospective Market Scenario in Sales by Region: 2018-2023
3.2 Global Viibryd (Vilazodone) Retrospective Market Scenario in Revenue by Region: 2018-2023
3.3 North America Viibryd (Vilazodone) Market Facts & Figures by Country
3.3.1 North America Viibryd (Vilazodone) Sales by Country
3.3.2 North America Viibryd (Vilazodone) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Viibryd (Vilazodone) Market Facts & Figures by Country
3.4.1 Europe Viibryd (Vilazodone) Sales by Country
3.4.2 Europe Viibryd (Vilazodone) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Viibryd (Vilazodone) Market Facts & Figures by Region
3.5.1 Asia Pacific Viibryd (Vilazodone) Sales by Region
3.5.2 Asia Pacific Viibryd (Vilazodone) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Viibryd (Vilazodone) Market Facts & Figures by Country
3.6.1 Latin America Viibryd (Vilazodone) Sales by Country
3.6.2 Latin America Viibryd (Vilazodone) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Viibryd (Vilazodone) Market Facts & Figures by Country
3.7.1 Middle East and Africa Viibryd (Vilazodone) Sales by Country
3.7.2 Middle East and Africa Viibryd (Vilazodone) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Viibryd (Vilazodone) Historic Market Analysis by Type
4.1 Global Viibryd (Vilazodone) Sales Market Share by Type (2018-2023)
4.2 Global Viibryd (Vilazodone) Revenue Market Share by Type (2018-2023)
4.3 Global Viibryd (Vilazodone) Price by Type (2018-2023)
5 Global Viibryd (Vilazodone) Historic Market Analysis by Application
5.1 Global Viibryd (Vilazodone) Sales Market Share by Application (2018-2023)
5.2 Global Viibryd (Vilazodone) Revenue Market Share by Application (2018-2023)
5.3 Global Viibryd (Vilazodone) Price by Application (2018-2023)
6 Key Companies Profiled
6.1 Allergan plc (AbbVie Inc.)
6.1.1 Allergan plc (AbbVie Inc.) Corporation Information
6.1.2 Allergan plc (AbbVie Inc.) Description and Business Overview
6.1.3 Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) Product Portfolio
6.1.5 Allergan plc (AbbVie Inc.) Recent Developments/Updates
6.2 Actavis Generics (Teva)
6.2.1 Actavis Generics (Teva) Corporation Information
6.2.2 Actavis Generics (Teva) Description and Business Overview
6.2.3 Actavis Generics (Teva) Viibryd (Vilazodone) Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Actavis Generics (Teva) Viibryd (Vilazodone) Product Portfolio
6.2.5 Actavis Generics (Teva) Recent Developments/Updates
6.3 Clinical Data, Inc.
6.3.1 Clinical Data, Inc. Corporation Information
6.3.2 Clinical Data, Inc. Description and Business Overview
6.3.3 Clinical Data, Inc. Viibryd (Vilazodone) Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Clinical Data, Inc. Viibryd (Vilazodone) Product Portfolio
6.3.5 Clinical Data, Inc. Recent Developments/Updates
7 Viibryd (Vilazodone) Manufacturing Cost Analysis
7.1 Viibryd (Vilazodone) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Viibryd (Vilazodone)
7.4 Viibryd (Vilazodone) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Viibryd (Vilazodone) Distributors List
8.3 Viibryd (Vilazodone) Customers
9 Viibryd (Vilazodone) Market Dynamics
9.1 Viibryd (Vilazodone) Industry Trends
9.2 Viibryd (Vilazodone) Market Drivers
9.3 Viibryd (Vilazodone) Market Challenges
9.4 Viibryd (Vilazodone) Market Restraints
10 Global Market Forecast
10.1 Viibryd (Vilazodone) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Viibryd (Vilazodone) by Type (2024-2029)
10.1.2 Global Forecasted Revenue of Viibryd (Vilazodone) by Type (2024-2029)
10.2 Viibryd (Vilazodone) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Viibryd (Vilazodone) by Application (2024-2029)
10.2.2 Global Forecasted Revenue of Viibryd (Vilazodone) by Application (2024-2029)
10.3 Viibryd (Vilazodone) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Viibryd (Vilazodone) by Region (2024-2029)
10.3.2 Global Forecasted Revenue of Viibryd (Vilazodone) by Region (2024-2029)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Viibryd (Vilazodone) Sales Growth Rate Comparison by Type (2023-2029) & (K Units) & (US$ Million)
Table 2. Global Viibryd (Vilazodone) Sales Growth Rate Comparison by Application (2023-2029) & (K Units) & (US$ Million)
Table 3. Global Viibryd (Vilazodone) Market Size by Region (US$ Million) (2018 VS 2022 VS 2029)
Table 4. Global Viibryd (Vilazodone) Market Competitive Situation by Manufacturers in 2022
Table 5. Global Viibryd (Vilazodone) Sales (K Units) of Key Manufacturers (2018-2023)
Table 6. Global Viibryd (Vilazodone) Sales Market Share by Manufacturers (2018-2023)
Table 7. Global Viibryd (Vilazodone) Revenue (US$ Million) by Manufacturers (2018-2023)
Table 8. Global Viibryd (Vilazodone) Revenue Share by Manufacturers (2018-2023)
Table 9. Global Market Viibryd (Vilazodone) Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 10. Manufacturers Viibryd (Vilazodone) Manufacturing Sites and Area Served
Table 11. Manufacturers Viibryd (Vilazodone) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Viibryd (Vilazodone) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Viibryd (Vilazodone) as of 2022)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Viibryd (Vilazodone) Sales by Region (2018-2023) & (K Units)
Table 16. Global Viibryd (Vilazodone) Sales Market Share by Region (2018-2023)
Table 17. Global Viibryd (Vilazodone) Revenue by Region (2018-2023) & (US$ Million)
Table 18. Global Viibryd (Vilazodone) Revenue Market Share by Region (2018-2023)
Table 19. North America Viibryd (Vilazodone) Sales by Country (2018-2023) & (K Units)
Table 20. North America Viibryd (Vilazodone) Sales Market Share by Country (2018-2023)
Table 21. North America Viibryd (Vilazodone) Revenue by Country (2018-2023) & (US$ Million)
Table 22. North America Viibryd (Vilazodone) Revenue Market Share by Country (2018-2023)
Table 23. Europe Viibryd (Vilazodone) Sales by Country (2018-2023) & (K Units)
Table 24. Europe Viibryd (Vilazodone) Sales Market Share by Country (2018-2023)
Table 25. Europe Viibryd (Vilazodone) Revenue by Country (2018-2023) & (US$ Million)
Table 26. Europe Viibryd (Vilazodone) Revenue Market Share by Country (2018-2023)
Table 27. Asia Pacific Viibryd (Vilazodone) Sales by Region (2018-2023) & (K Units)
Table 28. Asia Pacific Viibryd (Vilazodone) Sales Market Share by Region (2018-2023)
Table 29. Asia Pacific Viibryd (Vilazodone) Revenue by Region (2018-2023) & (US$ Million)
Table 30. Asia Pacific Viibryd (Vilazodone) Revenue Market Share by Region (2018-2023)
Table 31. Latin America Viibryd (Vilazodone) Sales by Country (2018-2023) & (K Units)
Table 32. Latin America Viibryd (Vilazodone) Sales Market Share by Country (2018-2023)
Table 33. Latin America Viibryd (Vilazodone) Revenue by Country (2018-2023) & (US$ Million)
Table 34. Latin America Viibryd (Vilazodone) Revenue Market Share by Country (2018-2023)
Table 35. Middle East and Africa Viibryd (Vilazodone) Sales by Country (2018-2023) & (K Units)
Table 36. Middle East and Africa Viibryd (Vilazodone) Sales Market Share by Country (2018-2023)
Table 37. Middle East and Africa Viibryd (Vilazodone) Revenue by Country (2018-2023) & (US$ Million)
Table 38. Middle East and Africa Viibryd (Vilazodone) Revenue Market Share by Country (2018-2023)
Table 39. Global Viibryd (Vilazodone) Sales by Type (2018-2023) & (K Units)
Table 40. Global Viibryd (Vilazodone) Sales Market Share by Type (2018-2023)
Table 41. Global Viibryd (Vilazodone) Revenue by Type (2018-2023) & (US$ Million)
Table 42. Global Viibryd (Vilazodone) Revenue Share by Type (2018-2023)
Table 43. Global Viibryd (Vilazodone) Price by Type (2018-2023) & (USD/Unit)
Table 44. Global Viibryd (Vilazodone) Sales (K Units) by Application (2018-2023)
Table 45. Global Viibryd (Vilazodone) Sales Market Share by Application (2018-2023)
Table 46. Global Viibryd (Vilazodone) Revenue by Application (2018-2023) & (US$ Million)
Table 47. Global Viibryd (Vilazodone) Revenue Share by Application (2018-2023)
Table 48. Global Viibryd (Vilazodone) Price by Application (2018-2023) & (USD/Unit)
Table 49. Allergan plc (AbbVie Inc.) Corporation Information
Table 50. Allergan plc (AbbVie Inc.) Description and Business Overview
Table 51. Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 52. Allergan plc (AbbVie Inc.) Viibryd (Vilazodone) Product
Table 53. Allergan plc (AbbVie Inc.) Recent Developments/Updates
Table 54. Actavis Generics (Teva) Corporation Information
Table 55. Actavis Generics (Teva) Description and Business Overview
Table 56. Actavis Generics (Teva) Viibryd (Vilazodone) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 57. Actavis Generics (Teva) Viibryd (Vilazodone) Product
Table 58. Actavis Generics (Teva) Recent Developments/Updates
Table 59. Clinical Data, Inc. Corporation Information
Table 60. Clinical Data, Inc. Description and Business Overview
Table 61. Clinical Data, Inc. Viibryd (Vilazodone) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 62. Clinical Data, Inc. Viibryd (Vilazodone) Product
Table 63. Clinical Data, Inc. Recent Developments/Updates
Table 64. Production Base and Market Concentration Rate of Raw Material
Table 65. Key Suppliers of Raw Materials
Table 66. Viibryd (Vilazodone) Distributors List
Table 67. Viibryd (Vilazodone) Customers List
Table 68. Viibryd (Vilazodone) Market Trends
Table 69. Viibryd (Vilazodone) Market Drivers
Table 70. Viibryd (Vilazodone) Market Challenges
Table 71. Viibryd (Vilazodone) Market Restraints
Table 72. Global Viibryd (Vilazodone) Sales Forecast by Type (2024-2029) & (K Units)
Table 73. Global Viibryd (Vilazodone) Sales Market Share Forecast by Type (2024-2029)
Table 74. Global Viibryd (Vilazodone) Revenue Forecast by Type (2024-2029) & (US$ Million)
Table 75. Global Viibryd (Vilazodone) Revenue Market Share Forecast by Type (2024-2029)
Table 76. Global Viibryd (Vilazodone) Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Viibryd (Vilazodone) Sales Market Share Forecast by Application (2024-2029)
Table 78. Global Viibryd (Vilazodone) Revenue Forecast by Application (2024-2029) & (US$ Million)
Table 79. Global Viibryd (Vilazodone) Revenue Market Share Forecast by Application (2024-2029)
Table 80. Global Viibryd (Vilazodone) Sales Forecast by Region (2024-2029) & (K Units)
Table 81. Global Viibryd (Vilazodone) Sales Market Share Forecast by Region (2024-2029)
Table 82. Global Viibryd (Vilazodone) Revenue Forecast by Region (2024-2029) & (US$ Million)
Table 83. Global Viibryd (Vilazodone) Revenue Market Share Forecast by Region (2024-2029)
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Viibryd (Vilazodone)
Figure 2. Global Viibryd (Vilazodone) Market Share by Type in 2022 & 2029
Figure 3. 10 mg Product Picture
Figure 4. 20 mg Product Picture
Figure 5. 40 mg Product Picture
Figure 6. Global Viibryd (Vilazodone) Market Share by Application in 2022 & 2029
Figure 7. Major Depression
Figure 8. Anxiety
Figure 9. Others
Figure 10. Global Viibryd (Vilazodone) Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 11. Global Viibryd (Vilazodone) Market Size (2018-2029) & (US$ Million)
Figure 12. Global Viibryd (Vilazodone) Sales (2018-2029) & (K Units)
Figure 13. Viibryd (Vilazodone) Sales Share by Manufacturers in 2022
Figure 14. Global Viibryd (Vilazodone) Revenue Share by Manufacturers in 2022
Figure 15. The Global 5 and 10 Largest Viibryd (Vilazodone) Players: Market Share by Revenue in 2022
Figure 16. Viibryd (Vilazodone) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 17. Global Viibryd (Vilazodone) Sales Market Share by Region (2018-2023)
Figure 18. Global Viibryd (Vilazodone) Sales Market Share by Region in 2022
Figure 19. Global Viibryd (Vilazodone) Revenue Market Share by Region (2018-2023)
Figure 20. Global Viibryd (Vilazodone) Revenue Market Share by Region in 2022
Figure 21. U.S. Viibryd (Vilazodone) Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 22. Canada Viibryd (Vilazodone) Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 23. Germany Viibryd (Vilazodone) Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 24. France Viibryd (Vilazodone) Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 25. U.K. Viibryd (Vilazodone) Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 26. Italy Viibryd (Vilazodone) Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 27. Russia Viibryd (Vilazodone) Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 28. China Viibryd (Vilazodone) Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 29. Japan Viibryd (Vilazodone) Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 30. South Korea Viibryd (Vilazodone) Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 31. India Viibryd (Vilazodone) Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 32. Australia Viibryd (Vilazodone) Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 33. Taiwan Viibryd (Vilazodone) Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 34. Indonesia Viibryd (Vilazodone) Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 35. Thailand Viibryd (Vilazodone) Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 36. Malaysia Viibryd (Vilazodone) Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 37. Philippines Viibryd (Vilazodone) Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 38. Vietnam Viibryd (Vilazodone) Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 39. Mexico Viibryd (Vilazodone) Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 40. Brazil Viibryd (Vilazodone) Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 41. Argentina Viibryd (Vilazodone) Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 42. Turkey Viibryd (Vilazodone) Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 43. Saudi Arabia Viibryd (Vilazodone) Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 44. U.A.E Viibryd (Vilazodone) Revenue Growth Rate (2018-2023) & (US$ Million)
Figure 45. Sales Market Share of Viibryd (Vilazodone) by Type (2018-2023)
Figure 46. Manufacturing Cost Structure of Viibryd (Vilazodone)
Figure 47. Manufacturing Process Analysis of Viibryd (Vilazodone)
Figure 48. Viibryd (Vilazodone) Industrial Chain Analysis
Figure 49. Channels of Distribution
Figure 50. Distributors Profiles
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Industry Market Size
